100120 — Vieworks Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Vieworks Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	160,264	193,139	237,929	220,251	222,898
Cost of Revenue
Gross Profit	82,657	95,693	109,417	95,294	95,586
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	131,198	158,383	194,271	202,143	201,511
Operating Profit	29,066	34,756	43,658	18,107	21,387
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	27,980	39,610	33,059	16,689	25,601
Provision for Income Taxes
Net Income After Taxes	22,959	33,500	26,459	14,759	21,094
Minority Interest
Net Income Before Extraordinary Items
Net Income	22,893	33,474	26,539	14,715	21,297
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22,893	33,474	26,539	14,715	21,297
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2,400	3,582	2,923	1,672	2,415
Dividends per Share